Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.

Heme Oxygenase-1 in Tumor Biology and Therapy

Was, Halina, Dulak, Jozef, Jozkowicz, Alicja · 2010 · Current Drug Targets

Abstract

Heme oxygenase-1 (HO-1) degrades heme to carbon monoxide (CO), biliverdin, and ferrous iron. As HO-1 expression is highly increased by stressful conditions, the major role of the enzyme is the protection against oxidative injury. Additionally, it regulates cell proliferation, modulates inflammatory response and facilitates angiogenesis. Beneficial activities of HO-1 have been recognized in many pathological states e.g. atherosclerosis, diabetes, ischemia/reperfusion injury or organ transplantation. Interestingly HO-1 expression is very often boosted in tumor tissues and could be further elevated in response to radio-, chemo-, or photodynamic therapy. A growing body of evidence suggests that HO-1 may play a role in tumor induction and can potently improve the growth and spread of tumors. This review discusses the implications of HO-1 properties for tumor proliferation and cell death, differentiation, angiogenesis and metastasis, and tumor-related inflammation. Finally, it suggests that pharmacological agents that regulate HO activity or HO-1 gene silencing may become powerful tools for preventing the onset or progression of various cancers and sensitize them to anticancer therapies. Keywords: Heme oxygenase-1, carcinogenesis, oxidative stress, cytoprotection, angiogenesis, metastasis, carbon monoxide (CO), biliverdin, ferrous iron, oxidative injury, atherosclerosis, diabetes, ischemia/reperfusion injury, photodynamic therapy, anticancer therapies, aneuploidy, malignancy, heterozygosity, serine/threonine kinases, Oncogenes, Tumor-associated angiogenic factors, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), reactive oxygen species (ROS), cytotoxicity, apoptotic/necrotic cell death, superoxide dismutase (SOD), biliverdin reductase (BvR), glucoronidated, UDPglucuronyl transferase, Purkinje cells, cerebellum, ferriporphyrins, ferrohemoglobin, hemopexin, haptoglobin, soluble guanylyl cyclase (sGC), tumor necrosis factor (TNF), interleukin-1β (IL-1β), macrophage inflammatory protein-1β (MIP-1β), lymphosarcoma, Kaposi sarcoma, viral G protein-coupled receptor (vGPCR), namely a-fetoprotein (AFP), Wilm's tumor protein-1 (WT-1), hepatocarcinogenesis, Squamous carcinoma, human gliomas, hormonerefractory prostate cancer (HRPCA), localized prostate cancer (PCA), activator protein-1 (AP-1), TUMOR CELL PROLIFERATION, mesoporphyrin-IX, cobalt protoporphyrin-IX (CoPPIX), cyclin-dependent kinase (Cdk), 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK), Sp1 (Stimulatory protein-1), vascular smooth muscle cells (VSMC), retinoblastoma protein (Rb), desferroxamine (DFO), mesenchymal stem cells (MSC), dimethyl sulfoxide (DMSO), haematopoietic, endothelial progenitor cells (EPC), APOPTOSIS, ZnPPIX-poly ZnPPIX-polyethylene, glycol (ZnPPIX-PEG), epigallocatechin 3-gallate (EGCG), anticancerogenic polyphenol, iron regulatory proteins (IRP1, transferrin receptor (TfR), astroglia, myelogenous leukemia cells, keratinocytes, matrix metalloproteinase-1 (MMP-1), thymidyne phosphorylase (TP), stroma cell-derived growth factor-1 (SDF-1), splenomegaly, lymphadenopathy, lipopolysaccharide (LPS), c-Jun N-terminal kinase, colony, –, stimulating factor (GMCSF), toll-like receptor-4 (TLR4), oral squamous cell carcinoma (OSCC), tin mesoporphyrin-IX (SnMPIX, telomerase reverse transcriptase (TERT)

Overview

Integrity signals

Registry

Crossref · 10.2174/1389450111009011551

Cites

299 of 299 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 297 references

Cited by

See all 277

Metadata

Authors
Was, H., Dulak, J., & Jozkowicz, A.
Venue
Current Drug Targets
Published
2010-12-01
Volume
11
Issue
12
Pages
1551-1570
ISSN
1389-4501 (ISSN-L)
OpenAlex
W2142595050
Cited by
259
References
297
Citations by year
2026: 9 · 2025: 11 · 2024: 11 · 2023: 3 · 2022: 14 · 2021: 18 · 2020: 12 · 2019: 12 · 2018: 18 · 2017: 20 · 2016: 23 · 2015: 34 · 2014: 25 · 2013: 17 · 2012: 20
FWCI
6.38
Type
journal article
Language
en
Open access
closed
Locations
  • Current Drug Targets (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
heme oxygenase-1, cancer, oxidative stress, angiogenesis, metastasis, tumor inflammation, carbon monoxide, biliverdin, ferrous iron, carcinogenesis, cancer therapy, photodynamic therapy, apoptosis, reactive oxygen species, cell proliferation, cell death, gene silencing, hepatocarcinogenesis, glioma, Kaposi's sarcoma
MeSH terms
Animals, Anti-Inflammatory Agents, Non-Steroidal, Cell Differentiation, Enzyme Induction, Humans, Inflammation, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Polymorphism, Genetic, Precancerous Conditions, Gene Expression Regulation, Neoplastic, Apoptosis, Oxidative Stress, Cell Proliferation, Heme Oxygenase-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heme Oxygenase-1 in Tumor Biology and Therapy. https://app.cochat.ai/papers/10.2174/1389450111009011551
The paper
Was, H., Dulak, J., & Jozkowicz, A. (2010). Heme Oxygenase-1 in Tumor Biology and Therapy. Current Drug Targets. https://doi.org/10.2174/1389450111009011551

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.